San Diego-primarily based Viking Therapeutics marked alone as a significant competitor while in the weight loss drug current market in February soon after revealing promising facts from a mid-phase demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when offered being a weekly injection and in Ma… Read More